Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,341
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,860
Class I recallsReasonable probability of serious health consequences
24,450
Class II recallsTemporary or medically reversible health consequences
2,901
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,095 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,450
Class I9,860
Class III2,901
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,450
Class I9,860
Class III2,901
Not Yet Classified2

Showing 7,941–7,960 of 17,454 recalls

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

SOD-PHOS (PHOS 3MMOL/ML-SOD 4MEQ/ML) PFV INJ SOLN, 10 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0905-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

SODIUM BICARBONATE 8.4% (1 MEQ/ML) INJ SOLN (PFV), 50 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0957-50

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

RIBOFLAVIN 0.1% OPHTHALMIC SOLUTION SYRINGE, 2 ML per syringe. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0923-02

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

PYRIDOXINE (PFV) 100MG/ML, 30ML PER VIAL. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0955-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

PYRIDOXINE (MDV) 100MG/ML, 30ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0956-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

PROCAINE HCL 8% (PFV) INJECTABLE, 10ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0970-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

PROCAINE HCL (PFV) 20 MG/ML INJECTABLE SOLUTION, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0900-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

PHO-TID-CHOL 50MG/ DEOXYCHOLIC 42 MG/ML INJ, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0953-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

ONDANSETRON 2 MG/ML INJECTION SOLUTION (PFV), 2 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0158-02

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

MOXIFLOXACIN 0.5% OPHTH SOLUTION SYRINGE, 1 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0973-81

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

MORPHINE 1MG/ML IN NACL 0.9% 55ML SYR (C-II), 55 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0138-89

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

MOLYBDENUM 0.025MG/ML INJECTION SOLUTION, 10ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0964-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

MIC B12 W/B6 (LIPOSTAT PLUS) 25/50/50/1/.175 MG/ML, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0978-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

METHYLCOBALAMIN (PFV) 10 MG/ML INJECTABLE, 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0902-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

METHYLCOBALAMIN 10MG/ML INJECTABLE SOLUTION (MDV), 10 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0130-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

MANGANESE SULFATE MONOHYDRATE (PFV) 0.1MG/ML INJ, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0952-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

MAGNESIUM CHLORIDE HEXAHYDRATE (PFV) 20% INJ SOLN, 50 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0951-50

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

MAGNESIUM CHLORIDE HEXAHYDRATE (MDV) 20% INJ SOLN, 50 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0977-50

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

LIDOCAINE HCL 2% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0172-20

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

KETAMINE 10 MG/ML INJ SOL SYR (C-III), [a) 2 ML NDC: 70731-0132-02; b) 5 ML NDC: 70731-0132-05] per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.